BRIEF-Davidson Kempner Capital Management Lp Says Fully Committed To Acquiring Vacasa And Now Offering $5.83 Per Share In Cash - SEC Filing-February 2024-www.financetom.com

BRIEF-Davidson Kempner Capital Management Lp Says Fully Committed To Acquiring Vacasa And Now Offering $5.83 Per Share In Cash - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Davidson Kempner Capital Management Lp Says Fully Committed To Acquiring Vacasa And Now Offering $5.83 Per Share In Cash - SEC Filing

Mar 31, 2025 3:49 PM

March 31 (Reuters) -

* DAVIDSON KEMPNER CAPITAL MANAGEMENT LP SAYS FULLY

COMMITTED TO

ACQUIRING VACASA AND NOW OFFERING $5.83 PER SHARE IN CASH - SEC

FILING

* DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - REITERATE SERIOUS

CONCERNS REGARDING THE SPECIAL COMMITTEE'S HANDLING OF SALE

PROCESS FOR VACASA, INC

Source text:

Previous page： dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday Next page： CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday

Oct 7, 2024

06:45 AM EDT, 10/07/2024 (MT Newswires) -- dynaCERT (DYA.TO), which jumped more than 30% and hit fresh 52 week highs last Friday, over the weekend announced that it has received the final Verra approval of its Carbon Credit Methodology. In a statement dynaCert said this Verra-approved methodology marks a significant milestone in the company's ongoing business evolution, as it underscores...

CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO

Oct 7, 2024

Oct 7 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting a valuation of up to $283 million in its initial public offering in the United States. The company will join a pack of biotech firms that have listed their shares recently as a long-awaited policy-easing cycle begins. Startups are...

Canadian Natural Resources Lifts Quarterly Dividend 7%, Shares Up 0.2% in US Premarket Trading

Oct 7, 2024

06:38 AM EDT, 10/07/2024 (MT Newswires) -- Canadian Natural Resources ( CNQ ) rose 0.2% in US premarket trading on Monday after saying it will boost its quarterly dividend 7% to $0.5625 per common share. The company said the dividend boost is in conjunction with the acquisition of Chevron Canada's (CVX) Alberta assets and as a result of its significant...

Pfizer Eyed By Starboard for Shareholder Rights Campaign

Oct 7, 2024

06:44 AM EDT, 10/07/2024 (MT Newswires) -- Pfizer ( PFE ) may become the target of a shareholder campaign led by Starboard Value, which has taken a $1 billion stake in the company, multiple news outlets reported Sunday. Reuters reported that Starboard, an activist investment advisory firm, wants to improve Pfizer's ( PFE ) performance and has already approached former...